US loss of exclusivity · Cardiometabolic
Trulicity
Eli Lilly
2027
US biosimilars from
2025
Today: 2026
2037
2025 worldwide sales
$4.3B
Date basis
Company guidance
US biosimilars
Early development
Medicare price
Pending, from 2028
Pharma Patent Cliff
by readouts.io
Data checked 24 October 2026 ·
Full Trulicity timeline →